Indeed, ex vivo studies by the Whiteside Lab have shown that tumour-derived EVs were immunosuppressive, and induced apoptosis of activated primary CD8+ cells, whilst T-cell- or dendritic-cell-derived EVs were immunostimulatory and promoted ex vivo proliferation of resting T-cells [78]. This evidence concerns the gene CD8A and neoplasm.